CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8
Clinical trials for CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8 trials appear
Sign up with your email to follow new studies for CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise against advanced melanoma before surgery
Disease control CompletedThis study tested whether giving a combination of targeted drugs (vemurafenib and cobimetinib) and immunotherapy (atezolizumab) before surgery could help people with high-risk stage III melanoma. 64 participants received the treatment, and doctors measured how many had no cancer …
Matched conditions: CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 17, 2026 12:06 UTC
-
New program aims to ease distress for young cancer survivors
Knowledge-focused CompletedThis completed study tested a program called INSPIRE-AYA for adolescent and young adult cancer survivors. The program used a mobile app, telehealth support, and educational materials to help survivors access healthcare resources and manage their health. Researchers measured chang…
Matched conditions: CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated Jun 23, 2026 11:59 UTC